Evaluation of an Optical Defocus Treatment for Myopia Progression Among Schoolchildren During the COVID-19 Pandemic | Ophthalmology | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Evaluation of an Optical Defocus Treatment for Myopia Progression Among Schoolchildren During the COVID-19 Pandemic

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME
Key Points

Question  Is an optical defocus treatment associated with slowed myopia progression among schoolchildren experiencing lockdown related to the COVID-19 pandemic?

Findings  In this exploratory analysis of 2 cohort studies including 171 schoolchildren during COVID-19 lockdown, treatment using a defocus incorporated multiple segments lens was associated with 46% less myopia progression and 34% less axial elongation compared with regular single vision lens treatment.

Meaning  These findings suggest that an optical defocus treatment may be associated with slower myopia progression, which has been exaggerated during the COVID-19 pandemic, among schoolchildren.

Abstract

Importance  Myopia progression has been found to be worsening during the COVID-19 pandemic. It is important to control the rapid myopia progression in this period.

Objective  To analyze the association of COVID-19–related lockdown measures with myopia progression in schoolchildren and to compare the performance of defocus incorporated multiple segments (DIMS) lens with that of single vision lens (SVL) treatment in reducing myopia progression.

Design, Setting, and Participants  This cohort study involved an exploratory, prespecified, comparison of 2 independent longitudinal studies performed at the same institute beginning in 2019. Data from Hong Kong schoolchildren (aged 7-13 years) were gathered and analyzed. Data analysis was performed from June to July 2021.

Exposure  Schoolchildren in study 1 wore a DIMS lens for 18 months, and those in study 2 wore a SVL for 24 months.

Main Outcomes and Measures  Cycloplegic spherical equivalent refraction and axial length were measured. Studies 1 and 2 started before the start of lockdown measures and continued throughout the lockdown. In both studies, periods of fewer and more COVID-19–related lockdown measures were identified. Because COVID-19 lockdown caused deviations from the visit schedule, myopia progression was normalized to 12-month change, which were compared between DIMS and SVL groups, also during the periods with less and more lockdown time.

Results  There were 115 participants (58 girls [50.4%]; mean [SD] age, 10.3 [1.5] years) in the DIMS group; their mean (SD) baseline refraction was −4.02 (1.46) D. There were 56 participants (29 girls [51.8%]; mean [SD] age, 10.8 [1.5] years) in the SVL group; their mean (SD) baseline refraction was −2.99 (1.06) D. After controlling for the covariates, DIMS treatment was significantly associated with 34% less axial elongation (0.19 mm [95% CI, 0.16 to 0.22 mm] vs 0.30 mm [95% CI, 0.25 to 0.35 mm]; P < .001) and 46% less myopic progression after 12 months (−0.31 D [95% CI, −0.39 to −0.23 D] vs −0.57 D [95% CI, −0.69 to −0.45 D]; P = .001) compared with SVL treatment. In both the DIMS and SVL groups, more lockdown time was associated with significantly more spherical equivalent refraction (−0.54 D [95% CI, −0.64 to 0.44 D] vs −0.34 D [95% CI, −0.44 to −0.25 D]; P = .01) and axial length (0.29 mm [95% CI, 0.25 to 0.32 mm] vs 0.20 mm [95% CI, 0.16 to 0.24 mm]; P = .001) compared with less lockdown time. No significant interaction between treatment type and lockdown time was observed.

Conclusions and Relevance  In this exploratory analysis, myopia progressed more rapidly in schoolchildren during the period when there were more COVID-19–related lockdown measures. However, optical treatment with DIMS was significantly associated with slower myopia progression compared with SVL treatment during the lockdown period.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: November 22, 2021.

Published: January 14, 2022. doi:10.1001/jamanetworkopen.2021.43781

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Choi KY et al. JAMA Network Open.

Corresponding Author: Henry Ho-lung Chan, PhD, Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong 00000 (henryhl.chan@polyu.edu.hk).

Author Contributions: Drs Chun and Chan had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Choi and Chun are co–first authors.

Concept and design: Choi, Chun, To, Lam, Chan.

Acquisition, analysis, or interpretation of data: Chun, Tang, Lam, Chan.

Drafting of the manuscript: Choi, Chun, Tang.

Critical revision of the manuscript for important intellectual content: Choi, Chun, To, Lam, Chan.

Statistical analysis: Choi, Chun, Tang, Lam.

Obtained funding: Chun, To, Chan.

Administrative, technical, or material support: Chun, Tang, To, Lam, Chan.

Supervision: Chan.

Conflict of Interest Disclosures: Dr Lam reported receiving a patent for DIMS lens with royalties paid from Hoya Corporation. No other disclosures were reported.

Funding/Support: This study was supported by the PolyU-HKIF Children Eye Care Project, the General Research Fund from the Research Grants Council (PolyU grant 151001/17M), the Health and Medical Research Fund from the Food and Health Bureau (grant 05161146), the Innovation and Technology Fund, and the Government of the Hong Kong Special Administrative Region.

Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: Natalie Y. Y. Chan, BSc, Yvonne Y. T. Li, BSc, and Vivian W. Y. Lo, BSc (all from the School of Optometry, The Hong Kong Polytechnic University), assisted with data collection. They were not compensated for this work beyond their normal salaries.

References
1.
World Health Organization. WHO coronavirus (COVID-19) dashboard. Accessed July 7, 2021. https://covid19.who.int/
2.
UNESCO. UNESCO COVID-19 education response: how many students are at risk of not returning to school? July 30, 2020. Accessed July 7, 2021. https://unesdoc.unesco.org/ark:/48223/pf0000373992
3.
Wong  CW , Tsai  A , Jonas  JB ,  et al.  Digital screen time during the COVID-19 pandemic: risk for a further myopia boom?   Am J Ophthalmol. 2021;223:333-337. doi:10.1016/j.ajo.2020.07.034PubMedGoogle ScholarCrossref
4.
Wang  W , Zhu  L , Zheng  S ,  et al.  Survey on the progression of myopia in children and adolescents in Chongqing during COVID-19 pandemic.   Front Public Health. 2021;9:646770. doi:10.3389/fpubh.2021.646770PubMedGoogle Scholar
5.
Liu  J , Li  B , Sun  Y , Chen  Q , Dang  J .  Adolescent vision health during the outbreak of COVID-19: association between digital screen use and myopia progression.   Front Pediatr. 2021;9:662984. doi:10.3389/fped.2021.662984PubMedGoogle Scholar
6.
Rose  KA , Morgan  IG , Ip  J ,  et al.  Outdoor activity reduces the prevalence of myopia in children.   Ophthalmology. 2008;115(8):1279-1285. doi:10.1016/j.ophtha.2007.12.019PubMedGoogle ScholarCrossref
7.
French  AN , Morgan  IG , Mitchell  P , Rose  KA .  Risk factors for incident myopia in Australian schoolchildren: the Sydney adolescent vascular and eye study.   Ophthalmology. 2013;120(10):2100-2108. doi:10.1016/j.ophtha.2013.02.035PubMedGoogle ScholarCrossref
8.
Wu  PC , Tsai  CL , Wu  HL , Yang  YH , Kuo  HK .  Outdoor activity during class recess reduces myopia onset and progression in school children.   Ophthalmology. 2013;120(5):1080-1085. doi:10.1016/j.ophtha.2012.11.009PubMedGoogle ScholarCrossref
9.
Huang  HM , Chang  DST , Wu  PC .  The association between near work activities and myopia in children: a systematic review and meta-analysis.   PLoS One. 2015;10(10):e0140419. doi:10.1371/journal.pone.0140419PubMedGoogle Scholar
10.
Choi  KY , Mok  AYT , Do  CW , Lee  PH , Chan  HHH .  The diversified defocus profile of the near-work environment and myopia development.   Ophthalmic Physiol Opt. 2020;40(4):463-471. doi:10.1111/opo.12698PubMedGoogle ScholarCrossref
11.
Ip  JM , Rose  KA , Morgan  IG , Burlutsky  G , Mitchell  P .  Myopia and the urban environment: findings in a sample of 12-year-old Australian school children.   Invest Ophthalmol Vis Sci. 2008;49(9):3858-3863. doi:10.1167/iovs.07-1451PubMedGoogle ScholarCrossref
12.
Choi  KY , Yu  WY , Lam  CHI ,  et al.  Childhood exposure to constricted living space: a possible environmental threat for myopia development.   Ophthalmic Physiol Opt. 2017;37(5):568-575. doi:10.1111/opo.12397PubMedGoogle ScholarCrossref
13.
Xu  L , Ma  Y , Yuan  J ,  et al; Myopic Epidemiology and Intervention Study.  COVID-19 quarantine reveals that behavioral changes have an effect on myopia progression.   Ophthalmology. 2021;128(11):1652-1654. doi:10.1016/j.ophtha.2021.04.001PubMedGoogle ScholarCrossref
14.
Ma  D , Wei  S , Li  S-M ,  et al.  Progression of myopia in a natural cohort of Chinese children during COVID-19 pandemic.   Graefes Arch Clin Exp Ophthalmol. 2021;259(9):2813-2820. doi:10.1007/s00417-021-05305-xPubMedGoogle ScholarCrossref
15.
Zhang  X , Cheung  SSL , Chan  H-N ,  et al.  Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study.   Br J Ophthalmol. Published online August 2, 2021. doi:10.1136/bjophthalmol-2021-319307PubMedGoogle Scholar
16.
Morgan  IG , French  AN , Ashby  RS ,  et al.  The epidemics of myopia: aetiology and prevention.   Prog Retin Eye Res. 2018;62:134-149. doi:10.1016/j.preteyeres.2017.09.004PubMedGoogle ScholarCrossref
17.
Holden  BA , Fricke  TR , Wilson  DA ,  et al.  Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050.   Ophthalmology. 2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006PubMedGoogle ScholarCrossref
18.
Morgan  IG , Ohno-Matsui  K , Saw  SM .  Myopia.   Lancet. 2012;379(9827):1739-1748. doi:10.1016/S0140-6736(12)60272-4PubMedGoogle ScholarCrossref
19.
Chia  A , Chua  WH , Cheung  YB ,  et al.  Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).   Ophthalmology. 2012;119(2):347-354. doi:10.1016/j.ophtha.2011.07.031PubMedGoogle ScholarCrossref
20.
Cho  P , Cheung  SW .  Retardation of Myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial.   Invest Ophthalmol Vis Sci. 2012;53(11):7077-7085. doi:10.1167/iovs.12-10565PubMedGoogle ScholarCrossref
21.
Lam  CSY , Tang  WC , Tse  DY , Tang  YY , To  CH .  Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial.   Br J Ophthalmol. 2014;98(1):40-45. doi:10.1136/bjophthalmol-2013-303914PubMedGoogle ScholarCrossref
22.
Yam  JC , Jiang  Y , Tang  SM ,  et al.  Low-concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control.   Ophthalmology. 2019;126(1):113-124. doi:10.1016/j.ophtha.2018.05.029PubMedGoogle ScholarCrossref
23.
Tse  DY , Lam  CSY , Guggenheim  JA ,  et al.  Simultaneous defocus integration during refractive development.   Invest Ophthalmol Vis Sci. 2007;48(12):5352-5359. doi:10.1167/iovs.07-0383PubMedGoogle ScholarCrossref
24.
Tse  DY , To  CH .  Graded competing regional myopic and hyperopic defocus produce summated emmetropization set points in chick.   Invest Ophthalmol Vis Sci. 2011;52(11):8056-8062. doi:10.1167/iovs.10-5207PubMedGoogle ScholarCrossref
25.
McFadden  SA , Tse  DY , Bowrey  HE ,  et al.  Integration of defocus by dual power Fresnel lenses inhibits myopia in the mammalian eye.   Invest Ophthalmol Vis Sci. 2014;55(2):908-917. doi:10.1167/iovs.13-11724PubMedGoogle ScholarCrossref
26.
Arumugam  B , Hung  LF , To  CH , Holden  B , Smith  EL  III .  The effects of simultaneous dual focus lenses on refractive development in infant monkeys.   Invest Ophthalmol Vis Sci. 2014;55(11):7423-7432. doi:10.1167/iovs.14-14250PubMedGoogle ScholarCrossref
27.
Lam  CSY , Tang  WC , Tse  DYY ,  et al.  Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial.   Br J Ophthalmol. 2020;104(3):363-368. doi:10.1136/bjophthalmol-2018-313739PubMedGoogle ScholarCrossref
28.
Wang  J , Li  Y , Musch  DC ,  et al.  Progression of myopia in school-aged children after COVID-19 home confinement.   JAMA Ophthalmol. 2021;139(3):293-300. doi:10.1001/jamaophthalmol.2020.6239PubMedGoogle ScholarCrossref
29.
World Medical Association.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.   JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053Google ScholarCrossref
30.
The Hong Kong Special Administrative Region Education Bureau. Chronology of Events in relation to the outbreak of novel coronavirus infection. May 2020. Accessed December 13, 2021. https://www.edb.gov.hk/attachment/en/curriculum-development/resource-support/learning-teaching-resource-list/COVID-19/Chronology%20of%20Events-COVID19-as%20at%205%20May%202020.pdf
31.
Erdinest  N , London  N , Levinger  N , Lavy  I , Pras  E , Morad  Y .  Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns.   Cont Lens Anterior Eye. 2021;101475. doi:10.1016/j.clae.2021.101475PubMedGoogle Scholar
32.
Yazdani  N , Sadeghi  R , Momeni-Moghaddam  H , Zarifmahmoudi  L , Ehsaei  A .  Comparison of cyclopentolate versus tropicamide cycloplegia: a systematic review and meta-analysis.   J Optom. 2018;11(3):135-143. doi:10.1016/j.optom.2017.09.001PubMedGoogle ScholarCrossref
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close